Vectura Group Receives Sell Rating from N+1 Singer (VEC)
Vectura Group (LON:VEC)‘s stock had its “sell” rating reaffirmed by equities researchers at N+1 Singer in a research report issued on Thursday, Analyst Ratings Network.com reports. They currently have a GBX 110 ($1.80) target price on the stock. N+1 Singer’s target price indicates a potential downside of 29.49% from the stock’s previous close.
Shares of Vectura Group (LON:VEC) opened at 155.332 on Thursday. Vectura Group has a 1-year low of GBX 76.00 and a 1-year high of GBX 165.00. The stock’s 50-day moving average is GBX 151.3 and its 200-day moving average is GBX 119.9. The company’s market cap is £526.9 million.
A number of other analysts have also recently weighed in on VEC. Analysts at FinnCap reiterated a “buy” rating on shares of Vectura Group in a research note on Thursday. They now have a GBX 180 ($2.95) price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Vectura Group in a research note on Wednesday, February 5th. Two investment analysts have rated the stock with a sell rating and eight have given a buy rating to the company. Vectura Group currently has an average rating of “Buy” and an average price target of GBX 148.88 ($2.44).
Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.